1. Introduction
===============

Atrial fibrillation (AF) occupies the leading position of sustained tachyarrhythmia with an increasing prevalence in human,^\[[@R1]\]^ which is associated with stroke, myocardial infarction, and heart failure and brings large economic burden to the patients' families and the society.^\[[@R2],[@R3]\]^ However, the pathogenesis of AF has not been fully clarified. Age, male sex, hypertension, ischemic heart disease, heart failure, valvular heart diseases, obesity, diabetes, hyperthyroidism, smoking, alcohol abuse, and pulmonary diseases are recognized as risk factors in the development of AF.^\[[@R4]\]^ However, some AF patients younger than 60 years without common risk factors are considered as having lone AF.^\[[@R5]\]^

With the rapid development of sequencing technology, much progress has been made in genetic investigation on AF. The role of genetics is becoming robust. Recently, a great number of rare variants in specific genes has been detected to be associated with AF.^\[[@R6]\]^ There have been \>30 genes encoding proteins regarding to AF published so far. Currently, plenty of studies indicated that mutations in ion channel genes increased the risk of AF.^\[[@R7]\]^ It has been indicated that loss-of-function potassium channel mutations can result in prolongation of atrial action potentials, which is associated with early afterdepolarizations and AF.^\[[@R8]\]^ Mutations in such genes are likely to be associated with disease causality or susceptibility and sometimes present clear family segregation.^\[[@R9],[@R10]\]^ Understanding its genetic background is important for better personalized management in the near future.^\[[@R11],[@R12]\]^

Studies in recent years have repeatedly reported that K~V~7.1, the α-subunit of the slowly activating delayed rectifier potassium current (I~Ks~) current, is involved in the pathogenesis of AF.^\[[@R13]\]^ The K~V~7.1 channel could significantly change its biophysical properties through co-expression of regulatory β-subunits attributing to *KCNE1* gene.^\[[@R14]\]^ In 1989, Murai et al^\[[@R15]\]^ first discovered *KCNE1* gene, which is located in the 21q22.1-22.2 region. The β-subunits of I~Ks~ encoded by KCNE1 contain 130 amino acids, which was also termed as Mink protein. The functional G38S polymorphism (A \>G) of *KCNE1* gene results in a serine to glycine substitution.^\[[@R16]\]^ Based on these, KCNE1 may be a promising biomarker for assessing the risk of AF.

For the past 10 years, many case-control designed studies^\[[@R17]--[@R30]\]^ regarding *KCNE1* G38S polymorphism and AF have been published, but because of the low statistical power and small sample size of individual studies, the consolidated result is still controversial. Among the 14 studies, 8 of them^\[[@R17],[@R19],[@R20],[@R24]--[@R26],[@R28],[@R29]\]^ reported association between KCNE1 G38S polymorphism and risk of AF, whereas the other 6 studies^\[[@R18],[@R21]--[@R23],[@R27],[@R30]\]^ reported no significant association. So we conducted the present meta-analysis to evaluate the association between KCNE1 G38S polymorphism and AF.

2. Methods
==========

We performed our meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).^\[[@R31]\]^ Since our meta-analysis was based on previously published studies, the ethical approval and patient consent were not required.

2.1. Search strategy
--------------------

We performed a systematic computerized literature search of to identify relevant articles in PubMed, Embase, OVID, Web of Science, Wan Fang, and CNKI databases up to March 10, 2017, combined with a manual search of reference lists from identified articles in English and Chinese languages. The following combination of medical subject headings or suitable key words was used in the literature search: AF, G38S, rs1805127, KCNE1, polymorphism, variant, and mutation. We have also searched the references of relevant review articles and of all the obtained case-control studies individually to discover possible eligible studies (Supplementary Digital Content).

2.2. Selection and exclusion criteria
-------------------------------------

We have pre-established criteria to elaborate the selection for studies obtained in this meta-analysis. The inclusion criteria were: studies with case-control designs; studies investigated the association of the KCNE1 G38S polymorphism and susceptibility to AF; studies that provided sufficient data to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for extraction. The criteria for exclusion were: studies that provided too limited data for extraction; review articles, abstracts-only articles, meta-analyses, and unpublished studies; inclusion of data duplicated in other studies.

2.3. Data extraction
--------------------

Two of the authors (Y-FJ, MD, and MC, MD) individually extracted all useful data of each study involving in this meta-analysis. Conflicts were discussed with a third investigator (Y-FZ, PhD). Extraction of study data includes: author; publication year; country of the work established, ethnicities, number of patients and control individuals, source of controls, genotyping method, and genotypes distribution. We made attempts to contact the original authors for detailed information if the data were incomplete or missing in the publication. Study quality was evaluated according to the 9-point Newcastle-Ottawa Scale (NOS).^\[[@R32]\]^

2.4. Statistical analysis
-------------------------

For each study included in this meta-analysis, we performed Hardy--Weinberg equilibrium (HWE) tests for evaluation of included populations. We investigate the strength of the associations between KCNE1 G38S polymorphism and susceptibility to AF by combining ORs and 95% 95% CIs under a fixed or random-effect model according to the quantification of the heterogeneity calculated with the *I*^2^ test. *I*^2^ ranges between 0 to 100% and represents the extent of interstudy heterogeneity. A random-effect model (Der Simonian and Laird method) for pooled analysis should be adopted when *I*^2^ \>50% indicating heterogeneity among studies. Otherwise the fixed-effect model (Mantel-Haenszel method) should be used. We also performed subgroup analyses to identify the possible underlying heterogeneity according to ethnicity, study sample size, source of control, and genotyping methods. The overall and subgroup analyses were both conducted in 5 genetic models: allele (G allele distribution frequency of KCNE1 gene G38S polymorphism), homozygote model (GG vs. AA), heterozygote model (AG vs. AA), recessive model (GG vs. AG + AA) and dominant model (GG + AG vs. AA), respectively. Sensitivity analysis was performed by combining ORs repeatedly with omission of each study to identify potential alternation of the overall meta result. We have also investigated publication bias via calculating Egger test and drawing Begg funnel plot. *P* \> .05 was considered that there was no statistically significant bias of publication. Meta-analysis was performed using Stata version 14.0 (Stata Corporation).

3. Results
==========

3.1. Study characteristics
--------------------------

The search of the 6 databases identified 162 records in total. After removing duplicated studies, there were 58 studies left for screening and 37 of records were excluded. Twenty-one studies were read by full-text, and 7 of full-text articles were excluded because of unmatched study design (n  =  4), insufficient data (n  =  1), and not relevant to AF (n  =  2). Figure [1](#F1){ref-type="fig"} shows the complete procedure of the study selection and exclusion. There were eventually 14 studies^\[[@R17]--[@R30]\]^ of 2810 cases and 3080 controls eligible for this meta-analysis on the relationship between *KCNE1* gene G38S polymorphism and AF. Characteristics of the studies included for meta-analysis are shown in Table [1](#T1){ref-type="table"}. Four^\[[@R18],[@R23],[@R24],[@R27]\]^ of these articles were published in Chinese and 10^\[[@R17],[@R19]--[@R22],[@R25],[@R26],[@R28]--[@R30]\]^ in English. The sample sizes ranged from 130 to 888 of all eligible studies. The races of the included studies were Chinese (n  =  11) and white (n  =  4). All the included studies except Andrzej et al^\[[@R20]\]^ fitted in with the HWE test. The results of NOS are shown in Table [2](#T2){ref-type="table"}. The NOS of all eligible studies in our meta-analysis was \>6 points, representing a good study quality. Genotype distribution and allele frequency in cases and controls of each study are shown in Table [3](#T3){ref-type="table"}.

![The PRISMA flow diagram of the study selection and exclusion.](medi-96-e7253-g001){#F1}
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Characteristics of the studies included for meta-analysis.
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The results of Newcastle-Ottawa Scale.
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KCNE1 G38S polymorphism genotype distribution and allele frequency in cases and controls.

![](medi-96-e7253-g004)

3.2. Quantitative synthesis
---------------------------

The present meta-analysis indicated significant association between *KCNE1* gene G38S polymorphism and AF under allelic (OR: 1.34, 95% CI: 1.24--1.45, *P* \< .001, *P*~heterogeneity~  =  .06), homozygous (OR: 1.90, 95% CI: 1.61--2.24, *P* \< .001, *P*~heterogeneity~  =  .15), heterozygous (OR: 1.43, 95% CI: 1.21--1.68, *P* \< .001, *P*~heterogeneity~  =  .60), recessive (OR: 1.42, 95% CI: 1.20--1.69, *P* \< .001, *P*~heterogeneity~  =  .01), dominant genetic model (OR: 1.62, 95% CI: 1.39--1.89, *P* \< .001, *P*~heterogeneity~  =  .71) in the whole population (Fig. [2](#F2){ref-type="fig"}).

![Forest plot from the meta-analysis on the association of the KCNE1 G38S polymorphism and AF risk in (A) allele model: G vs. A; (B) homozygote model: GG vs. AA; (C) heterozygote model: AG vs. AA; (D) recessive model: GG vs. AG + AA; and (E) dominant model: GG + AG vs. AA. AF  =  atrial fibrillation, CI  =  confidence interval, OR  =  odds ratio.](medi-96-e7253-g005){#F2}

In the subgroup analyses by ethnicity (Fig. [3](#F3){ref-type="fig"}), the association grew stronger with higher ORs in white under all genetic models: allelic (OR: 1.49, 95% CI: 1.28--1.73, *P* \< .001, *P*~heterogeneity~  =  .18), homozygous (OR: 2.76, 95% CI: 1.38--5.54, *P*  =  .01, *P*~heterogeneity~  =  .04), heterozygous (OR: 1.51, 95% CI: 1.13--2.04, *P*  =  .006, *P*~heterogeneity~  =  .99), recessive (OR: 2.03, 95% CI: 1.12--3.68, *P*  =  .02, *P*~heterogeneity~  =  .01), dominant genetic model (OR: 1.75, 95% CI: 1.32--2.31, *P* \< .001, *P*~heterogeneity~  =  .81). In the Chinese subgroup, we also found significant association under allelic (OR: 1.30, 95% CI: 1.19--1.42, *P* \< .001, *P*~heterogeneity~  =  .11), homozygous (OR: 1.77, 95% CI: 1.45--2.16, *P* \< .001, *P*~heterogeneity~  =  .41), heterozygous (OR: 1.39, 95% CI: 1.14--1.69, *P*  =  .001, *P*~heterogeneity~  =  .36), recessive (OR: 1.34, 95% CI: 1.13--1.59, *P*  =  .001, *P*~heterogeneity~  =  .04), dominant genetic model (OR: 1.57, 95% CI: 1.31--1.88, *P* \< .001, *P*~heterogeneity~  =  .54). In summary, our meta-analysis suggested that G38S polymorphism in the *KCNE1* gene significantly increase the risk of AF, particularly in white. We also conducted subgroup analyses according to source of control, sample size, and genotyping method. The detailed information was presented in Table [4](#T4){ref-type="table"}. Similar association was indicated in both Chinese and white. Similar association was observed in each subgroup that G38S polymorphism in the *KCNE1* gene significantly increase the risk of AF.

![Subgroup meta-analysis by ethnicity of the relationship between the KCNE1 G38S polymorphism and AF risk in (A) allele model: G vs. A; (B) homozygote model: GG vs. AA; (C) heterozygote model: AG vs. AA; (D) recessive model: GG vs. AG + AA and (E) dominant model: GG + AG vs. AA. AF  =  atrial fibrillation, CI  =  confidence interval, OR  =  odds ratio.](medi-96-e7253-g006){#F3}

###### 

Subgroup analyses of association between KCNE1 G38S polymorphism and atrial fibrillation.
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3.3. Sensitivity analysis
-------------------------

We conducted the sensitivity analysis to discover whether the omission of each study will alter the pooled ORs quantitatively. As shown in Figure [4](#F4){ref-type="fig"}, no altered results are shown after the individual study was omitted, which provided reliable evidence to prove the increased risk of the KCNE1 G38S polymorphism to AF susceptibility (Fig. [4](#F4){ref-type="fig"}).

![Sensitivity analysis of the pooled OR coefficients on the relationship between KCNE1 G38S polymorphism and AF risk. AF  =  atrial fibrillation, CI  =  confidence interval, OR  =  odds ratio.](medi-96-e7253-g008){#F4}

3.4. Publication bias
---------------------

When performing a meta-analysis, publication bias is no doubtfully a common problem to be addressed. In our meta-analysis, we calculated Egger test and drew the Begg funnel plot to assess the publication bias. Visually from the Begg funnel plot (Fig. [5](#F5){ref-type="fig"}), we could see all the 14 studies were symmetrically distributed on the 2 sides, which indicated no publication bias in our meta-analysis (Egger test: *P*  =  .08).

![Begg funnel plot with pseudo 95% confidence limits in recessive model.](medi-96-e7253-g009){#F5}

4. Discussion
=============

To date, many case-control studies focusing on the relationship between KCNE1 G38S polymorphism and risk of AF have been published, but the results remain controversial. Of the 14 studies included in our study, 8 studies^\[[@R17],[@R19],[@R20],[@R24]--[@R26],[@R28],[@R29]\]^ reported association between KCNE1 G38S polymorphism and risk of AF, whereas the other 6 studies^\[[@R18],[@R21]--[@R23],[@R27],[@R30]\]^ reported no significant association. Because of the conflicting results and small sample size of individual studies, the consolidated result is still controversial. Therefore, we conducted the present meta-analysis to investigate the relationship between KCNE1 G38S polymorphism and risk of AF.

Our meta-analysis consolidated 14 eligible studies on the KCNE1 G38S polymorphism and the relationship of AF. All of the results indicated that the KCNE1 G38S polymorphism would increase the risk of AF. Furthermore, subgroup analyses showed a higher risk of having AF in subjects with the risk allele in the white population, than in the Chinese population. Stratified analysis by ethnicity, sample size, source of control, and genotyping method presented the same situation. Although one study^\[[@R20]\]^ did not fit the HWE test in the control group, omission of this study during the sensitivity analysis did not alter the conclusions made in the meta-analysis. No publication bias was observed in our meta-analysis.

At present, the pathogenesis of AF has not been fully recognized. Lone AF may be associated with irregular ionic currents, whereas acquired AF is usually caused by atrial structural remodeling. Mutation in genes encoding the ion channel was considered as the pathologic factor of AF that reduced the I~Ks~.^\[[@R33]\]^ Evidence showed *KCNE1* gene encoding the I~Ks~ channel contributed to AF.^\[[@R34]\]^ On the term of physiology, cardiac I~Ks~ channel is involved in the atrial repolarization, especially in the terminal stage of action potential, which can result in shortening of the frequency-dependent action potential time interval and electricity remodeling of the atrial tissue. Chen et al^\[[@R35]\]^ found that the onset or maintenance of AF was related to the arrhythmia matrix formed by interaction of proteins encoded by KCNE1 G38S and other proteins. Accordingly, the *KCNE1* gene plays an important role in regulating cardiac rhythm.^\[[@R36]\]^

Understanding the genetic background is important for better personalized management in the near future. First, the KCNE1 G38S polymorphism can be used together with other related polymorphisms for risk stratification of developing AF.^\[[@R37]\]^ People with high genetic risk scores are at approximately twice incidence of AF and 23% increased risk of stroke. Second, specific polymorphisms are associated with recurrence of AF after catheter ablation.^\[[@R38],[@R39]\]^ Identification of these polymorphisms helps to determine the optimized therapy for individuals to receive ablation or drug therapy. Third, genetic risk scores for stroke in AF patients can guide clinicians on anticoagulant therapy.

In recent years, preclinical studies regarding genetic therapy on AF have been carried out. The key procedure of genetic therapy includes targeted delivery, tissue specificity, and functional expression.^\[[@R40]\]^ With the development of genetic therapy, we will gain more treatment options for AF. However, many aspects remain unknown. For example, how to ensure the inherent safety of genetic therapy in modifying the myocardium? How would the genetic material be delivered? Such issues should have been addressed before genetic therapy would be implemented in clinical practice.

Our meta-analysis did have some limitations. First, one study did not fit the HWE test in the control group. After omission of this study during the sensitivity analysis, it did not alter the conclusions made in the meta-analysis. Second, all of the 14 studies included in this meta-analysis were written in English and Chinese, so studies in other languages and possible unpublished articles did not attend this meta-analysis, which may cause selection bias. Third, there were no studies including Africans. Fourth, the genetic susceptibility may also depend on the coincidence of several gene polymorphisms acting together, which may influence the results.

By performing this meta-analysis, we finally concluded that the G38S polymorphism in the *KCNE1* gene significantly increases the risk of AF in both Chinese and white. As a variant in the potassium ion channel, it could be a promising loci for genetic therapy in the clinical management of AF in the future and more case-control studies need to be carried out to further validate and strengthen the conclusion of this meta-analysis.
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Abbreviations: CI = confidence interval, HB = hospital-based, HWE = Hardy--Weinberg equilibrium, I~Ks~ = slowly activating delayed rectifier potassium current, NOS = Newcastle-Ottawa scale, OR = odds ratio, PB = population-based, PCR-RFLP = polymerase chain reaction-restriction fragment length polymorphism, RAF = risk allele frequency.
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